Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kelderman Kim Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 8,191 restricted stock units @ $0
Granted 22,043 options to buy @ $84.61, valued at $1.9M
Granted 29,391 options to buy @ $84.61, valued at $2.5M
08/08/2023 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 4,139 shares @ $82.17, valued at $340.1k
Exercised 8,060 restricted stock units @ $0
08/25/2022 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Exercised 663 options to buy @ $150.78, valued at $100k
08/17/2022 4 Kelderman Kim (PRES. DIAGNOSTICS & GENOM) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 1,746 restricted stock units @ $0
Granted 5,426 options to buy @ $378.08, valued at $2.1M
Granted 7,235 options to buy @ $378.08, valued at $2.7M
08/09/2022 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 1,214 shares @ $382.97, valued at $464.9k
Exercised 2,363 restricted stock units @ $0
02/10/2022 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Exercised 1,989 options to buy @ $150.78, valued at $299.9k
11/23/2021 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Sold 100 shares @ $503.76, valued at $50.4k
Sold 400 shares @ $505.7825, valued at $202.3k
Exercised 500 options to buy @ $150.78, valued at $75.4k
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Sold 823 shares @ $388.45, valued at $319.7k
08/07/2020 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 2,015 restricted stock units @ $0
Granted 8,991 options to buy @ $267.87, valued at $2.4M
Granted 11,988 options to buy @ $267.87, valued at $3.2M
Granted 8,325 options to buy @ $267.87, valued at $2.2M
05/05/2020 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 821 shares @ $227.54, valued at $186.8k
Exercised 1,666 restricted stock units @ $0
08/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2019 4 Kelderman Kim (President, Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Exercised 1,667 shares @ $202.13, valued at $337k
Paid exercise price by delivering 844 shares @ $202.13, valued at $170.6k
Exercised 1,667 restricted stock units @ $0
08/10/2018 4 Kelderman Kim (President, Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 1,691 restricted stock units @ $0
Granted 12,044 options to buy @ $177.32, valued at $2.1M
Granted 9,033 options to buy @ $177.32, valued at $1.6M
05/03/2018 4 Kelderman Kim (President, Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 5,000 restricted stock units @ $0
Granted 2,652 options to buy @ $150.78, valued at $399.9k
Granted 7,348 options to buy @ $150.78, valued at $1.1M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy